LONG – TERM SAFETY OF REPLICATION-DEFECTIVE SMALLPOX VACCINE (MVA-BN) IN ATOPIC ECZEMA AND ALLERGIC RHINITIS

BACKGROUND: Availability of a safe smallpox vaccine may be necessary under certain circumstances. Use of the old life virus vaccine was associated with serious adverse events, particularly in the setting of atopic eczema and immunodeficiency. MVA(modified virus Ankara)-BN, a highly attenuated strain...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Eur Acad Dermatol Venereol
Autori principali: Darsow, U, Sbornik, M, Rombold, S, Katzer, K, von Sonnenburg, F, Behrendt, H, Ring, J
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5077702/
https://ncbi.nlm.nih.gov/pubmed/27357167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.13797
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi